CTI BIOPHARMA CORP 4
4 · CTI BIOPHARMA CORP · Filed Nov 20, 2015
Insider Transaction Report
Form 4
BIANCO LOUIS A
EVP, Finance & Administration
Transactions
- Sale
Common Stock
2015-11-19$1.15/sh−500$575→ 907,547 total - Sale
Common Stock
2015-11-19$1.16/sh−1,100$1,271→ 906,447 total - Sale
Common Stock
2015-11-19$1.13/sh−1,000$1,125→ 913,147 total - Sale
Common Stock
2015-11-19$1.13/sh−1,200$1,356→ 911,947 total - Sale
Common Stock
2015-11-19$1.14/sh−100$114→ 911,847 total - Sale
Common Stock
2015-11-19$1.14/sh−806$919→ 911,041 total - Sale
Common Stock
2015-11-19$1.15/sh−2,994$3,428→ 908,047 total - Sale
Common Stock
2015-11-19$1.16/sh−100$116→ 906,347 total - Sale
Common Stock
2015-11-19$1.10/sh−800$880→ 920,547 total - Sale
Common Stock
2015-11-19$1.10/sh−1,400$1,547→ 919,147 total - Sale
Common Stock
2015-11-19$1.11/sh−3,800$4,218→ 915,347 total - Sale
Common Stock
2015-11-19$1.11/sh−200$223→ 915,147 total - Sale
Common Stock
2015-11-19$1.12/sh−1,000$1,120→ 914,147 total
Holdings
- 37(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]The sale was effected pursuant to a Rule 10b5-1 trading plan.